Compare, Analyse CORAL LAB. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   TEVA PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-20
TEVA PHARMA
Dec-13
CORAL LAB./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3813,143-   
Low Rs812,731-   
Sales per share (Unadj.) Rs197.71,804.1-  
Earnings per share (Unadj.) Rs20.0112.7-  
Cash flow per share (Unadj.) Rs25.6258.5-  
Dividends per share (Unadj.) Rs098.66-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs324.02,004.0-  
Shares outstanding (eoy) m3.57848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.21.6 71.9%   
Avg P/E ratio x11.626.1 44.4%  
P/CF ratio (eoy) x9.011.4 79.6%  
Price / Book Value ratio x0.71.5 48.7%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m8262,490,652 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m970-   
Avg. sales/employee Rs ThNM34,038.2-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,126.3-  
INCOME DATA
Net Sales Rs m7061,529,847 0.0%  
Other income Rs m590-   
Total revenues Rs m7651,529,847 0.0%   
Gross profit Rs m54418,950 0.0%  
Depreciation Rs m20123,659 0.0%   
Interest Rs m230,049 0.0%   
Profit before tax Rs m91265,242 0.0%   
Minority Interest Rs m01,205 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-174,117 0.0%   
Tax Rs m20-3,238 -0.6%   
Profit after tax Rs m7195,568 0.1%  
Gross profit margin %7.727.4 28.1%  
Effective tax rate %21.8-1.2 -1,784.8%   
Net profit margin %10.16.2 161.7%  
BALANCE SHEET DATA
Current assets Rs m9581,033,253 0.1%   
Current liabilities Rs m251901,084 0.0%   
Net working cap to sales %100.28.6 1,160.2%  
Current ratio x3.81.1 333.2%  
Inventory Days Days13991 153.3%  
Debtors Days Days17896 185.5%  
Net fixed assets Rs m485499,682 0.1%   
Share capital Rs m363,766 0.9%   
"Free" reserves Rs m1,1210-   
Net worth Rs m1,1571,699,370 0.1%   
Long term debt Rs m0782,245 0.0%   
Total assets Rs m1,4433,496,191 0.0%  
Interest coverage x48.79.8 495.9%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.50.4 111.8%   
Return on assets %5.13.6 141.2%  
Return on equity %6.25.6 109.6%  
Return on capital %8.04.9 163.2%  
Exports to sales %66.20-   
Imports to sales %2.90-   
Net fx Rs m4410-   
CASH FLOW
From Operations Rs m-39243,778 -0.0%  
From Investments Rs m-16-86,381 0.0%  
From Financial Activity Rs m36-292,429 -0.0%  
Net Cashflow Rs m-19-135,031 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.31 Rs / USD

Compare CORAL LAB. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CORAL LAB. With: NORRIS MEDICINES  JENBURKT PH.  DISHMAN PHARMA  LINK PHARMA  RELISH PHARMA  



Today's Market

SGX Nifty Up 14 Points, HUL's Quarterly Performance, Tata Motors on EV Battery Prices, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a flat note yesterday. Dalal street's greatest winning streak in over ten months came to an end when benchmark indices fell for the first time in eight sessions.

Related Views On News

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

5 Exciting 'Unlisted' Companies and How to Play Them (Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CORAL LAB. SHARE PRICE


Oct 19, 2021 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CORAL LAB.

CORAL LAB. 8-QTR ANALYSIS

COMPARE CORAL LAB. WITH

FEATURED VIDEOS

Why a Simple Portfolio Beat Quality Bluechips by 2x

How to Pick Multibagger Stocks

IRCTC: Buy, Hold or Sell

What to Look for in an IPO

More Featured Videos

MARKET STATS